Speaker illustration

Doctor Shigetaka KAGEYAMA

National University of Ireland, Galway (Ireland)

Member of:

European Society of Cardiology

Ten-year mortality after percutaneous coronary intervention, off-pump and on-pump surgery for complex coronary artery disease - who is the winner?

Event: ESC Congress 2023

Topic: Circulatory Support

Session: Long-term outcomes after coronary artery bypass grafting

Thumbnail

Inter-corelab agreement of angiography-derived wall shear stress distribution

Event: ESC Congress 2023

Topic: Angiography, Invasive Imaging

Session: Invasive diagnostic tools in coronary artery disease

Thumbnail

Does the pre-procedural pathophysiological pattern impact post-procedural hemodynamic outcomes and vessel prognosis in multivessel coronary artery disease?

Event: ESC Congress 2023

Topic: Pathophysiology and Mechanisms

Session: Risk stratification in chronic coronary syndromes

Thumbnail

Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial

Event: ESC Congress 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session: Long-term PCI outcomes

Thumbnail

Angiographic derived physiological assessment after intervention for predicting 2-year vessel-oriented composite endpoints in Multivessel TALENT trial

Event: ESC Congress 2022

Topic: Percutaneous Coronary Intervention (PCI)

Session: Intravascular imaging / physiology: guiding PCI to improve outcomes

Thumbnail

Risk stratification on admission for predicting death or need for surgery in patients with acute type A intramural hematoma receiving medical therapy - validation cohort

Event: ESC Congress 2020

Topic: Aortic Dissection, Acute Intramural Haematoma

Session: Advancing Knowledge and Improvement of Care in Diseases of the Aorta

Thumbnail

The major bleeding event is the stronger predictor of long term mortality rather than the coronary event in the secondary prevention of ischemic heart disease in Japan

Event: ESC Congress 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Challenges in contemporary management of coronary artery disease

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb